Search
Empagliflozin is used in the treatment of 2 diabetic adults with diet combined with exercise who fail to achieve adequate glycemic control to improve glycemic control.
Empagliflozin mainly reduces plasma glucose levels by inhibiting the expression of SGLT-2, reducing renal glucose reabsorption and increasing the excretion of glucose in urine, and its hypoglycemic effect does not depend on β cell function and insulin resistance.
| Items | Specifications | Results |
| Appearance | White to off-white powder | Confirmed |
| Loss on drying | ≤0.5% | 0.2% |
| Residue on ignition | ≤0.5% | 0.1% |
| Water content | ≤0.3% | 0.2% |
| Purity | ≥99.5% | 99.9% |
| Product parameters | |
| Cas number: | 864070-44-0 |
| Appearance: | White to off-white powder |
| Purity: | 99.5%min |
| Package details: | 100g/bottle; 1kg/bag |
| Brand: | Fortunachem |

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية